Priced like the old business, running like a new one: management is redirecting the call away from the metric investors
The model's full reasoning — Q1 2016 call → NOWe need to determine if management repeatedly redirects attention away from the conventional measure and toward a different part of the business that is already earning, and indicates the record hasn't caught up. The transcript is about Curis, a biotech. They have CUDC-907, CA170, and Erivedge (partnered). The call discusses progress on CUDC-907 (Phase 2 trial), CA170 (oral checkpoint inhibitor entering clinic), and Erivedge (commercialized by partners). The financial results are typical: net loss, revenues from royalties on Erivedge. The question asks: does management repeatedly redirect attention away from the measure or storyline by which the company is conventionally judged and toward a different part of the business that it says is already earning today? And does management indicate that this different part is not yet what the company's reported results or outside understanding reflect? We need to identify what the conventional yardstick is. For a biotech with no approved products of its own (Erivedge is partnered, royalties), the conventional measure might be the progress of its pipeline, or perhaps the revenue from Erivedge royalties. But management is not setting aside a conventional yardstick. They are discussing their pipeline programs. They mention Erivedge is commercialized by partners, but they don't say that the conventional measure (maybe Erivedge royalties) is not the right thing to watch. They are not redirecting from one part to another. They are just giving updates on all programs. The call is a standard earnings call: they discuss financial results, pipeline progress. There is no indication that management is saying "the thing outsiders habitually watch is no longer the right thing to watch." They are not setting aside any metric. They are not saying that the reported figures don't reflect something. They are just reporting. The only possible redirection might be that they emphasize CUDC-907 and CA170 over Erivedge, but Erivedge is already commercialized and generating royalties. But they don't say that the conventional yardstick (maybe Erivedge revenue) is not the right thing. They just report royalties as part of revenue. They don't say that the company's future is in something else that is already earning but not reflected.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NOAH | Noah Holdings Limited | Q1 2024 | 2024-05-30 | D |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CALX | Calix, Inc. | Q1 2023 | 2023-04-20 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| LOB | Live Oak Bancshares, Inc. | Q3 2018 | 2018-10-25 | C+ |
SPT · Q2 2023 → YESThe question is whether management repeatedly redirects attention away from the conventional measure toward a different part of the business that's already earning today, and indicates that this diffe...YES The transcript shows management repeatedly reframing away from the conventional total ARR/revenue growth metric (which is being distorted by unpredictable low-end non-core ARR) toward the higher-quality up-market/enterprise segment that is already delivering record new business ACVs, 50%+ YoY growth, and 43% of 2023 ARR. They explicitly set the low-end aside by removing it from forecasts and modeling to give “greatest visibility,” note that Q2 ARR growth will be the lowest pace of the year because of this change, and indicate the reported figures still reflect the old mix while the new up-market story is already earning today (with Tagger adding further upside not yet reflected). This creates the coherent posture of redirecting attention from the headline growth number outsiders watch to the part of the business that is already producing real results.
WD · Q2 2022 → YESThe question is about whether management repeatedly redirects attention away from the conventional measure to a different part of the business that's already earning today, and indicates that this isn...YES The transcript shows management repeatedly reframing the discussion away from the conventional multifamily agency lender yardstick (origination volumes, GSE lending, MSR-driven EPS) toward the diversified services and asset-management businesses that are already generating substantial cash revenue and EBITDA today. They explicitly set the old metric aside by introducing adjusted EPS to “strip out non-cash mortgage servicing rights,” highlight the shift from “lending-centric” to “broader technology-enabled financial services,” and note that segment results now provide “more transparency into our operating structure.” They point to debt brokerage, property sales, SAM (Alliant, Zelman), small-balance lending, and appraisals as the new earning engines, describing their concrete contributions (e.g.
CALX · Q1 2023 → YESThe question is about whether management repeatedly redirects attention away from the conventional measure to a different part of the business that's already earning today, and indicates that this isn...YES The transcript shows management repeatedly framing the company as operating in a "new market" centered on platforms, clouds, and managed services—distinct from the legacy hardware/cyclical model—while highlighting real earnings from these areas (e.g., 988 BSPs deploying platforms, 865 cloud customers, 334 with 41 new managed services in Q1, record Intelligent Access EDGE revenue). They indicate this is already producing revenue and customer adoption but remains early-stage ("this is the beginning," "early stage of where we are in this new market"), with reported results still reflecting the prior hardware-focused picture.